A direct influence of dietary long-chain polyunsaturated fatty acids (LC-PUFA) on the developmental quotient (DO) of the healthy term infant remains unexplored. To test this hypothesis, we designed a prospective study of three types of diet. 'I'wentynine infants received a LC-PUFA-supplemented formula, 31 received a standard infant formula. and 30 infants were breastfed exclusively. Neurodevelopmental response was measured by the Brunet-LCzine psychomotor development test at 4 mo. The fatty acid status was also assessed among three diet subgroups (59 subjects) at 4 mo. Formula-fed infants who received LC-PUFA supplementation scored significantly higher (p < 0.01) on the Brunet-IRzine scale than infants who received the standard formula. Breast-fed infants also performed better than those fed the standard formula. Arachidonic acid and docosahexaenoic acid levels in circulating lipids and erythrocyte phospholipids were higher among breast-fed infants and among the group fed the arachidonic-and docosahexaenoic acid-supplemented for-
the Brunet-IRzine scale than infants who received the standard formula. Breast-fed infants also performed better than those fed the standard formula. Arachidonic acid and docosahexaenoic acid levels in circulating lipids and erythrocyte phospholipids were higher among breast-fed infants and among the group fed the arachidonic-and docosahexaenoic acid-supplemented forExperimental evidence is accruing that dietary supplementarion or deprivation of the precursors of LC-PUFA (LA and, in particul;ir, ALA) during the early stages of growth affect both LC-PUPA composition in nervous tissue and sensorymotor development (1) (2) (3) (4) . Decreased levels of DIIA (the major n-3 LC-PUFA derived from ALA) in the brain tissue of animals fed ALA-poor diets have been associated with altered learning patterns. Dietary supplementation with preformed DHA increases the DHA levels in animal brain tissue and improves learning skills ( 5 , 6) .
During the perinatal neural growth spurt, the placenta enriches the fetal circulation with AA (the major among n-6 LC-PUFA) and DHA in animals as well as humans (7) (8) (9) (10) . Postnatally, the ideal natural source of these fatty acids is breast milk (1 1) . Varying amounts of L A and ALA are to be mula. These findings are suggestive that formula supplementation with one or both of these fatty acids can benefit term infants in neurodevelopmental performance. found in most standard infant formulas, whereas preformed LC-PUFA are not. Plasma concentrations of LC-PUFA tend to be lower with formula feeding even though precursors be present (12, 13) . Among dietary LC-PUFA DHA is preferentially channeled into the brain phospholipids of human infants (14) . Brain levels of D H A are also associated with erythrocyte DHA levels (15) . Correlations between dietary amounts of AA, DHA, and LC-PUFA, their circulating and erythrocyte phospholipid levels, and performance at visual and behavioral assessments have been found by studies on preterm infants, particularly prone to LC-PUFA deficiency (16) (17) (18) (19) . A recent study found that there was a significant relationship between higher DHA erythrocyte concentrations and performance at visual acuity test among full-term, breast-fed infants (20) .
T o assess psychomotor development against LC-PUFA status in a population of 4-mo-old term infants, we rated on .2 g lactose, 3.6 g fat per 100 mL (energy: 67 kcall100 mL). The lipid mixture of the experimental formula included LC-PUFA of the n-3 and n-6 series. The fat blend was derived from palm oil, coconut and palm kernel fats, soybean oil, sunflower oil for its parent PUFA, and evening primrose oil for its y-linolenic (18:3n-6)-containing triglycerides. Egg lipids were added to provide LC-PUFA-containing phospholipids and triglycerides. Protocol. Parents gave their informed consent for enrollment, neurodevelopmental testing, and blood sampling and analysis. The Departmental Ethics Committee approved the study aims and design. Parents were also requested to adhere strictly to the prescribed diet (except on contrary medical advice min, and plasma rich in platelets was removed. Erythrocytes were resuspended in acid-citrate-dextrose and further centrifugated (four cycles). After osmotic shock the erythrocyte membranes were washed at high speed centrifugation and the final pellet was stored at -80°C until analyzed. The plasma for lipid extraction was obtained by centrifugation of plasma rich in platelets at 3000 rpm for 15 min after removal of the platelet pellet. Plasma lipids were extracted by stepwise addition of 1 mL water, 4 mL methanol, and 8 mL chloroform to 0.5 mL of plasma. After phase separation, the organic layer was collected and solvents evaporated under N, (27) . Lipids were extracted from erythrocyte membranes with chloroform-methanol (2:1, vol/vol) (28) and KC1 0.88% in the presence of the antioxidant butylated hydroxytoluene (5 pg/mL). Plasma lipid classes and erythrocyte phospholipids were separated by thin-layer chromatography (thin-layer chromatography silica gel plates 60, supplied by Merck of Darmstadt, FRG) using n-hexaneldiethyl etherfacetic acid (8012011, vol/vol) as developing solvents (29) . Fatty acid methyl esters were prepared by acid-catalyzed transmethylation with methanolic hydrochloride (Supelco, Bellefonte, PA) and separated by gas-chromatography (Carlo Erba model 4160, supplied by Fisons Instruments of Rodano, Italy, equipped with a flame ionization detector) and a fused silica capillary column (Supelco Omegawax 320, 30 m in length, 0.32-mm internal diameter, and 0.25 p m thick film), using a temperature program rising from 130 to 230°C by increments of 3"C/min. Separate peaks from the detector output were identified by using pure reference compounds (Supelco) and were expressed as weight %. Nonadecanoic acid 264 AGOSTONI ET AL.
(19:O) was added as internal standard to the sample before methyl ester preparation. The following fatty acids were identified for most plasma lipid classes and erythrocyte phospholipids: 16:0, 16:ln-7, 18:0, 18:ln-9, 18:2n-6, 18:3n-6, 18:3n-3, 20:3n-6, 20:4n-6, 20:5n-3, 22:4n-6, 22:5n-6, 22:5n-3, 22:6n-3. Fatty acid fractions of less than 0.2% were not considered.
Statistics. In planning trial size, the probability / 3 of a type I1 error fixed at 0.10 was considered acceptable to estimate clinical response with a DQ magnitude variation of 10% admissible for a clinically meaningful difference between groups. The number of subjects for the purpose of the study was calculated as 24 in each group. We then oversampled up to 30. With 24 subjects per feeding group, the differences between groups of the average fatty acid parameters yield a probability P of between 0.03 and 0.08 for a type I1 error measured as AA and DHA variation of 30 and 50%, respectively (12, 13) . The data are expressed as mean t SD. The 95% CI were calculated at 4 mo for the variables under study. Differences between DQ scores and fatty acid levels were tested by ANOVA. Categorical variables for socioeconomic indicators were compared using the 2 test. Comparison between group means was tested by the Newman-Keuls method. The limit of significance was set at 0.05. All statistical analyses were performed on the SPSS/PC+ statistical package (SPSSI PC+3.1; SPSS Inc., Chicago, IL). 75%, 107; 90%, 115; 95%, 122. The distribution of these observations falls within the distribution curves described by Brunet and Gzine, who report that 50% of their observed DQ scores in 725 subjects fall between 90 and 110 (6 subjects >125; 7 subjects <80; interobservation correlation of r = 0.85, with different monitors) (24) . A significant scoring difference can be seen between the enriched formula and the standard formula-fed groups (Table 3) . Breast-fed infants also scored higher than infants fed the standard formula. No difference for parental and socioeconomic factors was found between the three infant groups. The time-balanced randomization tables removed intergroup differences due to parental occupation and education status (data not shown).
Consent for blood sampling was obtained from the parents of 15 infants (50%) in HM, 23 in F1 (85%), and 19 in F2 (65%). The subjects not sampled did not present diffcrences in basic characteristics and DQ, when compared with infants of the same groups who underwent blood testing. Among infants who underwent blood sampling, the breast-fed and the supplemented formula-fed groups present AA and DHA levels in their circulating and erythrocyte lipids that are higher than those of infants fed the standard formula (Table 4) . Only erythrocyte AA levels were found to be higher among infants in the supplemented formula-fed group, whereas they were similar in the breast-fed and the standard formula-fed groups.
RESULTS DISCUSSION
Ninety subjects were recruited and thus allocated: 29 in group F1 (15 boys, 14 girls), 31 in F2 (16 boys, 15 girls), and 30 subjects in the HM group (13 boys, 17 girls). At 4 mo, 86 subjects underwent Brunet-LCzine's neurodevelopmental test. Four subjects (two girls in both F1 and F2) were too agitated and could not be assessed. Table 2 sets out the characteristics of the 86 infants.
The mean Brunet-LCzine score of our sample was 101 (SD, 11; 95% CI = 99-103). The minimum score reached was 80 and the maximum 136. The percentile cutoffs were obtained at the following points: 5%, 82; lo%, 86; 25%, 94; 50%, 101; This is the first study that directly connects the psychomotor performance of full-term infants at 4 mo with LC-PUFA of both the n-6 and 12-3 series integrated in a formula regimen. We speculated that if an enhanced neurodevelopmental response could be elicited among infants either breast-fed or fed a formula supplemented with LC-PUFA, this could be the effect of the presence of these fatty acids in their diet and could also account for their higher performance at psychomotor tests.
The preferential uptake by the developing brain of preformed, longer chain fatty acids with a higher degree of unsaturation (30, 31) can alter the lipid composition of neuron membranes and can also modulate brain neurotransmitter activity. A short-term effect of dietary LC-PUFA on the structural modification of membranes and the performance of sensorymotor function has indeed been experimentally and clinically demonstrated (4) (5) (6) (16) (17) (18) (19) . Sensory-motor performance was assessed to rate the neurodevelopmental response as DQ scores on Brunet-LCzine scale in contrast to earlier visual acuity (16, 19) or developmental studies (17, 18) of preterm infants who were fed n-3 LC-PUFA and whose response was assessed by different methods. HM is a natural source of LC-PUFA, and enriching a formula patterned on HM with AA and DHA also significantly correlates with higher DQ scores that quantify this response. Circulating and erythrocyte phospholipid levels of AA and DHA were also significantly higher. Brunet-LCzine scales (like other psychometric tests) quantify variations from the theoretical mean of an empirical developmental sequence. The infant DQ derived from psychometric tests shows a poor relationship with the intelligence quotient of older children (24, 26) . Then, that psychomotor infant development at 4 mo is directly influenced by the dietary intake of both AA and DHA does not ensure a predictive value of these results for childhood trends, and even less for later childhood development and beyond. The problem of the persistence of differences between groups supplied with n-3 LC-PUFA and controls has been addressed by animal studies (4, 6, 32) and is currently the focus of studies on preterm infants (16, 19) . Animals lacking dietary LC-PUFA in the early stages of growth show an age-related recovery of their structural lipid composition with a rehabilitation diet (4, 6, 32) . The possibility of a parallel functional improvement is still the object of debate. Midterm observations on animals and preterm infants are also often conflicting (4, 6, 16, 19, 32) .
The specific effect and nutritional mode of action of dietary AA and DHA in relation to neurodevelopmental response and dietary intervention planning are open questions for further study. The diet groups we studied are currently being followed and we will report on the medium-and long-term implications.
